Aemetis director sells 10,000 shares at ~$2.05
Aemetis, Inc. director Simon Timothy Alan sold shares in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aemetis, Inc. director Simon Timothy Alan sold shares in the company. He completed an open-market sale of 10,000 shares of Common Stock at a weighted average price of about $2.05 per share. After this transaction, he directly holds 42,632 shares of Aemetis Common Stock.
The reported sale price reflects a weighted average of multiple trades within a range of $2.04 to $2.06 per share, as noted in the footnote. The filing does not show any related option exercises or derivative positions, indicating this was a straightforward common stock sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $2.05 | $21K |
Footnotes (1)
- F1. The reported price is a weighted average of executions within a price range of $2.04 to $2.06
Key Figures
Key Terms
open-market sale financial
Common Stock financial
weighted average financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AEMETIS, INC (AMTX) report on this Form 4?
Was the AEMETIS (AMTX) Form 4 transaction an open-market sale or another type?
Does the AEMETIS (AMTX) Form 4 show any options or derivatives involved in the trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.